Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
申请人:AbbVie S.à.r.l.
公开号:US10428017B2
公开(公告)日:2019-10-01
The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Synthesis and free radical scavenging activity of some new spiropyranocoumarins
作者:Vassiliki Panteleon、Ioannis K. Kostakis、Panagiotis Marakos、Nicole Pouli、Ioanna Andreadou
DOI:10.1016/j.bmcl.2008.09.065
日期:2008.11
A series of novel spiro-substituted 4-hydroxypyranocoumarins and their corresponding dihydropyrano cis-diols has been synthesized. Among them the spiroadamantylpyranocoumarin and the diols can interact with the stable free radical 1,1-diphenyl-2-picrylhydrazyl and scavenge superoxide anions generated in the xanthine-xanthine oxidase system. (C) 2008 Elsevier Ltd. All rights reserved.